Toll-like receptor 9 is required for opioid-induced microglia apoptosis

Lei He1, Hui Li, Lin Chen

  • 1Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.

Plos One
|May 12, 2011
PubMed

Insights

Opioid abuse can harm the brain. This study reveals that morphine triggers microglia apoptosis via Toll-like receptor 9 (TLR9) and the µ-opioid receptor (µOR), suggesting new therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Opioids are potent analgesics but carry risks of abuse and adverse physiological effects.
  • The precise mechanisms underlying microglial responses to opioids are not fully understood.
  • Microglia play crucial roles in innate immunity and neuroinflammation.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which opioids, specifically morphine, induce microglial cell death.
  • To investigate the role of Toll-like receptor 9 (TLR9) and the µ-opioid receptor (µOR) in opioid-induced microglial apoptosis.
  • To identify potential therapeutic targets for preventing opioid-induced neurotoxicity.

Main Methods:

  • Investigated the effect of morphine on microglial apoptosis in vitro.
  • Utilized TLR9-deficient and µOR-deficient primary microglia.
  • Employed TLR9 inhibitor (CpGODN) and p38 MAPK inhibitor (SB203580).
  • Assessed expression levels of apoptosis-related proteins (Bcl-2, Bax) and MAPK pathway components (p38 MAPK, MKK3/6).

Main Results:

  • Morphine induced Toll-like receptor 9 (TLR9) expression and microglial apoptosis.
  • TLR9 deficiency or inhibition significantly reduced morphine-induced apoptosis.
  • Inhibition of p38 MAPK attenuated morphine-induced microglial apoptosis.
  • Morphine-induced apoptosis was dependent on both TLR9 and the µ-opioid receptor (µOR).
  • Morphine altered Bcl-2 and Bax levels in a TLR9-dependent manner.

Conclusions:

  • Opioids, via µOR activation, induce microglial apoptosis through TLR9 signaling and p38 MAPK activation.
  • TLR9 and µOR are critical mediators of opioid-induced neurotoxicity.
  • Inhibiting TLR9 or blocking µOR may offer neuroprotective strategies against opioid-induced brain damage.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.